Clinical Trials Arena on MSN
Blue Lake restarts paediatric RSV vaccine study after FDA clinical hold
After a Type C discussion, Blue Lake got the FDA nod to enrol both RSV-positive and negative children above the age of 18 ...
Stocks of COVID-19 vaccine makers take a dive following Washington Post report, while Moderna stresses multiple agencies have backed their safety Stocks of COVID vaccine makers dropped after the ...
Moderna Inc. said its vaccine to prevent cytomegalovirus, a common cause of birth defects, failed to meet its goal in a late-stage trial, a setback for the company still struggling to move past the ...
Moderna said it's planning to submit a request to the U.S. Food and Drug Administration to authorize a low-dose COVID-19 vaccine for children under 6 years old, part of a push to inoculate the 18 ...
Moderna is asking U.S. regulators to allow for use of its COVID-19 vaccine on the nation's youngest children. Moderna submitted data to the Food and Drug Administration Thursday for emergency use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback